Evidence map›Paper›PMID 39390774›Full record

ArticleVirulence2024

Bactericidal and anti-quorum sensing activity of repurposing drug Visomitin against

Ruolan Wu, Yuan Wu, Pingyun Wu, Huilong Li, Pengfei She

Abstract read
In one paragraph

Article in Virulence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [In vitro and in vivo antibacterial effects of the mitochondrial antioxidant Visomitin againstZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Extracellular Vesicles fromMicroorganisms · 2025
    Article
  10. DisarmingPathogens (Basel, Switzerland) · 2025
    Review
  11. Article
  12. Drug repurposing of Nifuratel against methicillin-resistantFrontiers in cellular and infection microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruolan WuDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Yuan WuDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Pingyun WuDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Huilong LiDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Pengfei SheDepartment of Laboratory Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.ORCID 0000-0002-4246-1361

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the growing antibiotic resistance in

Indexed as

Anti-Bacterial AgentsBiofilmsDrug RepositioningMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsQuorum SensingBacterial ProteinsHumansStaphylococcal InfectionsStaphylococcus aureusVirulenceAnti-Bacterial AgentsBacterial ProteinsantimicrobialbiofilmhaemolysisMethicillin-resistant Staphylococcus aureusquorum sensingVisomitin

Identifiers

PMID39390774
PMCPMC11492638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.